000 | 01961 a2200565 4500 | ||
---|---|---|---|
005 | 20250515072229.0 | ||
264 | 0 | _c20070731 | |
008 | 200707s 0 0 eng d | ||
022 | _a1465-993X | ||
024 | 7 |
_a10.1186/1465-9921-8-43 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLang, Dagmar S | |
245 | 0 | 0 |
_aA novel human ex vivo model for the analysis of molecular events during lung cancer chemotherapy. _h[electronic resource] |
260 |
_bRespiratory research _cJun 2007 |
||
300 |
_a43 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAntimetabolites, Antineoplastic _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Agents _xtherapeutic use |
650 | 0 | 4 |
_aAntineoplastic Agents, Phytogenic _xtherapeutic use |
650 | 0 | 4 |
_aApoptosis _xdrug effects |
650 | 0 | 4 |
_aBreast Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aCarboplatin _xtherapeutic use |
650 | 0 | 4 |
_aCarcinoma, Non-Small-Cell Lung _xdrug therapy |
650 | 0 | 4 |
_aCaspase 3 _xchemistry |
650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
650 | 0 | 4 | _aCells, Cultured |
650 | 0 | 4 |
_aDNA _xbiosynthesis |
650 | 0 | 4 |
_aDeoxycytidine _xanalogs & derivatives |
650 | 0 | 4 | _aDrug Resistance |
650 | 0 | 4 |
_aDrug Screening Assays, Antitumor _xmethods |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aIn Vitro Techniques |
650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
650 | 0 | 4 |
_aTissue Survival _xdrug effects |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aVinblastine _xanalogs & derivatives |
650 | 0 | 4 | _aVinorelbine |
650 | 0 | 4 | _aGemcitabine |
700 | 1 | _aDroemann, Daniel | |
700 | 1 | _aSchultz, Holger | |
700 | 1 | _aBranscheid, Detlev | |
700 | 1 | _aMartin, Christian | |
700 | 1 | _aRessmeyer, Anne R | |
700 | 1 | _aZabel, Peter | |
700 | 1 | _aVollmer, Ekkehard | |
700 | 1 | _aGoldmann, Torsten | |
773 | 0 |
_tRespiratory research _gvol. 8 _gp. 43 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1186/1465-9921-8-43 _zAvailable from publisher's website |
999 |
_c17106080 _d17106080 |